3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Neoplasms
2
Triple Negative Breast Neoplasms
1
Thoracic Neoplasms
1
Small Cell Lung Carcinoma
1
Sarcoma, Kaposi
1
Sarcoma, Ewing
1
Sarcoma
1
Rhabdomyosarcoma, Embryonal
1
Rhabdomyosarcoma, Alveolar
1
Rhabdomyosarcoma
1
Parkinson Disease 4, Autosomal Dominant Lewy Body
1
Pancreatic Neoplasms
1
Ovarian Neoplasms
1
Neuroectodermal Tumors, Primitive, Peripheral
1
Neuroblastoma
1
Melanoma
1
HIV Infections
1
Glioma
1
Carcinoma, Non-Small-Cell Lung
1
Carcinoma, Merkel Cell
1
Carcinoma
1
AIDS-related Kaposi sarcoma
1
Interventions
Rituximab
134
Cyclophosphamide
100
Vincristine
53
fludarabine phosphate
50
Prednisone
50
Doxorubicin
49
Etoposide
47
Peripheral Blood Stem Cell Transplantation
38
Mycophenolic Acid
37
Whole-Body Irradiation
35
Tacrolimus
29
Busulfan
27
Lenalidomide
26
Filgrastim
26
Cyclosporine
26
Melphalan
24
Methotrexate
21
Antilymphocyte Serum
21
Gemcitabine
18
ibritumomab tiuxetan
17
Granulocyte Colony-Stimulating Factor
17
Cytarabine
17
Carmustine
16
Radiotherapy
15
fludarabine
14
Carboplatin
14
Bendamustine Hydrochloride
14
pembrolizumab
13
ibrutinib
12
Sirolimus
11
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Lymphoma, Large B-Cell, Diffuse
×
efineptakin alfa
×
Clear all
No trials found.